Brain Fog: Cognitive Symptoms and the Clouded Mind

What it is

"Brain fog" is a colloquial term, not a formal diagnosis — but it names something real and remarkably common: a cluster of subjective cognitive difficulties that includes trouble concentrating, slowed or effortful thinking, forgetfulness, word-finding problems, and a general sense of mental cloudiness or lost sharpness. Clinically it corresponds to what is called cognitive dysfunction, and although the phrase is vague, the experience is specific and often deeply disabling. A first essential point is that brain fog is usually non-progressive and fluctuating, occurring in the context of another condition — which distinguishes it from the steady decline of dementia and from the acute, dangerous confusion of delirium.

Unpacking the fog: which functions

"Brain fog" is best understood by breaking it into the cognitive domains it can affect, because different conditions hit different ones:

Attention and concentration — the most common complaint, including difficulty sustaining focus and filtering distraction. Processing speed — thinking feels slow and laborious. Working memory — the mental scratchpad for holding and juggling information. Executive function — planning, multitasking, and mental flexibility. Verbal fluency — the frustrating tip-of-the-tongue, word-finding lapses. And episodic memory, though here a crucial subtlety applies: in depression especially, perceived memory problems often reflect impaired attention and effort (and a negative bias toward noticing one's failures) rather than true loss of memories.

A useful distinction separates "cold" cognition (emotionally neutral processes such as attention and processing speed) from "hot" cognition (emotionally charged processing, such as the negative attentional and memory biases of depression). Both contribute to brain fog, and they respond to different things.

Where it appears

Cognitive symptoms are profoundly transdiagnostic. They are a core, often residual feature of depression; one of the defining and most persistent symptoms of long COVID; prominent in ME/CFS and fibromyalgia ("fibrofog"); a recognized consequence of cancer treatment ("chemo brain"); common around menopause; and produced by thyroid disease, sleep deprivation, anxiety, post-concussion states, dysautonomia, and a long list of medications. The breadth is itself a clue that brain fog is a shared output of several different disturbances.

The neurobiology

Several mechanisms converge on cognitive function, and they overlap heavily with the mechanisms behind fatigue.

In depression, cognitive symptoms are linked to dysfunction in the prefrontal cortex and hippocampus, to the effects of stress hormones (cortisol) on the hippocampus, to reduced neuroplasticity and BDNF signaling, and to the monoamines norepinephrine and dopamine that support attention and executive control. Rumination — the default mode network intruding on task-focused thought — directly steals attention. Importantly, the "cold" cognitive deficits (processing speed, executive function) often do not fully lift when mood improves, which is why residual cognitive symptoms are such a problem.

Inflammation is the mechanism that best explains brain fog across the non-depressive conditions. The same cytokine-driven "sickness behavior" that produces fatigue also impairs cognition — slowing, inattention, mental cloudiness are part of the coordinated response. Neuroinflammation, activation of the brain's immune cells (microglia), and the neurotoxic byproducts of the kynurenine pathway are leading candidates for the cognitive symptoms of long COVID, chemo brain, and ME/CFS. Proposed long COVID mechanisms add microvascular and endothelial dysfunction, autoimmunity, and altered brain metabolism, though this science is still rapidly evolving. Sleep loss and circadian disruption degrade attention and working memory directly, and vascular and metabolic factors (blood flow, insulin resistance) contribute in others.

Why it matters

Cognitive symptoms are a major and under-appreciated driver of disability. In depression, cognitive dysfunction predicts difficulty returning to work even after mood has recovered, and residual cognitive symptoms predict relapse. In long COVID, brain fog is among the most disabling and persistent complaints. And because cognitive symptoms are invisible and may not show up on brief testing, sufferers are frequently disbelieved — adding the distress of invalidation to a genuine impairment.

Assessment

The practical priorities are: exclude delirium (acute, fluctuating confusion with impaired attention is a medical emergency, not brain fog); consider whether a progressive decline warrants evaluation for dementia; and check reversible contributors — thyroid function, B12 and vitamin D, sleep apnea, depression, and especially medications that impair cognition, such as anticholinergics, benzodiazepines, and other sedatives. A key nuance is that objective cognitive testing can be normal even when subjective impairment is real and disabling; the dissociation between felt and measured cognition is common, and both deserve to be taken seriously.

Treatment

Treating the underlying condition and removing reversible causes — including deprescribing cognitively-impairing medications — comes first, and is often the highest-yield step.

For the cognitive symptoms of depression, some antidepressants show pro-cognitive effects that appear partly independent of their effect on mood; vortioxetine has the strongest evidence here, with bupropion and duloxetine also relevant, and treating to full remission matters because lingering cognitive symptoms predict relapse. Behavioral and rehabilitative approaches — cognitive remediation, compensatory strategies, addressing rumination, sleep optimization, and especially exercise (which has reasonably good evidence for cognition) — are the mainstays across conditions. For long COVID and chemo brain, cognitive rehabilitation, pacing, and exercise as tolerated are used, but no pharmacotherapy is proven, and the honest message is that effective specific treatment is still lacking.

How it connects

Brain fog is the cognitive sibling of fatigue — mental fatigue and brain fog overlap substantially, and both are core features of inflammation's sickness-behavior program. It links to the neuroplasticity/BDNF hub through the hippocampus and prefrontal cortex, to the HPA-axis through cortisol's effects on memory, to sleep through attention, and to anhedonia and motivation through the effect of reduced drive on cognitive engagement.

Caveats

"Brain fog" is a non-specific lay term, valuable for communication but requiring unpacking into specific domains and causes before it can be addressed. Subjective and objective cognition can diverge, and both are valid. Delirium (urgent) and progressive dementia (needing workup) must be excluded. The negative cognitive bias of depression can inflate perceived deficits beyond measured ones. And the conditions in which "medically unexplained" brain fog is most prominent — long COVID, ME/CFS — are areas of active, unsettled science where dismissiveness is both common and unwarranted.

Bottom line

Brain fog is real, common, and disabling — a fluctuating impairment of attention, speed, memory, and executive function that arises across a wide range of conditions and shares much of its biology with fatigue, especially the inflammatory sickness-behavior response and the stress-and-plasticity effects on the prefrontal cortex and hippocampus. It matters because it drives disability and relapse and is frequently disbelieved. The sensible approach is to unpack the fog into its components, exclude delirium and reversible causes, deprescribe what is clouding the mind, treat the underlying condition (with attention to pro-cognitive options like vortioxetine in depression), and lean on rehabilitation and exercise — while taking the symptom, and the person reporting it, seriously even when the tests look normal.

Selected references

1. Rock PL, et al. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014.
2. McIntyre RS, et al. Cognitive deficits and functional outcomes in major depressive disorder. Depress Anxiety. 2013.
3. Roiser JP, Sahakian BJ. Hot and cold cognition in depression. CNS Spectr. 2013.
4. McIntyre RS, et al. The effects of vortioxetine on cognitive function in patients with major depressive disorder (CONNECT/FOCUS trials). Int J Neuropsychopharmacol. 2016.
5. Dantzer R, et al. From inflammation to sickness and depression. Nat Rev Neurosci. 2008.
6. Harrison NA, et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry. 2009.
7. Becker JH, et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open. 2021.
8. Davis HE, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023.
9. Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022.
10. Janelsins MC, et al. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014.
11. Maki PM, et al. Cognition and the menopause transition. Menopause. 2016.
12. Hammar Å, Årdal G. Cognitive functioning in major depression — a summary. Front Hum Neurosci. 2009.
13. Bowie CR, et al. Cognitive remediation for treatment-resistant depression. J Clin Psychiatry. 2013.
14. Hillman CH, Erickson KI, Kramer AF. Be smart, exercise your heart: exercise effects on brain and cognition. Nat Rev Neurosci. 2008.
15. Ross AJ, et al. What is brain fog? An evaluation of the symptom in postural tachycardia syndrome. Clin Auton Res. 2013.
16. Theoharides TC, et al. Brain fog, inflammation and obesity: key aspects of long COVID. Front Neurosci. 2022.